Morphine acts in vitro to directly prime nociceptors

Eugen V. Khomula,Jon D. Levine
DOI: https://doi.org/10.1177/17448069241260348
IF: 3.37
2024-06-05
Molecular Pain
Abstract:Molecular Pain, Volume 20, Issue , January-December 2024. Hyperalgesic priming is a preclinical model of the transition from acute to chronic pain characterized by a leftward shift in the dose-response curve for and marked prolongation of prostaglandin E2 (PGE2)-induced mechanical hyperalgesia, in vivo. In vitro, priming in nociceptors is characterized by a leftward shift in the concentration dependence for PGE2-induced nociceptor sensitization. In the present in vitro study we tested the hypothesis that a mu-opioid receptor (MOR) agonist opioid analgesic, morphine, can produce priming by its direct action on nociceptors. We report that treatment of nociceptors with morphine, in vitro, produces a leftward shift in the concentration dependence for PGE2-induced nociceptor sensitization. Our findings support the suggestion that opioids act directly on nociceptors to induce priming.
neurosciences
What problem does this paper attempt to address?